PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Rumex acetosella extract inhibits platelet aggregation, calcium mobilization, granule secretion, and fibrinogen binding to integrin αIIbβ3 [PMID:34546536]
Ethanol and ethanol-water extracts remarkably inhibited α-glucosidase [PMID:32744345]
The Essiac mixture containing sheep sorrel contains compounds with antioxidant activity and the ability to block cell growth [PMID:11365626]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 34546536 (2022) — Rumex acetosella Inhibits Platelet Function via Impaired MAPK and Phosphoinositide 3-Kinase Signaling. · Chinese journal of integrative medicine
- 2.PMID: 11365626 (1998) — Essiac for cancer? · TreatmentUpdate
- 3.PMID: 32744345 (2020) — Inhibitory potential on key enzymes relevant to type II diabetes mellitus and antioxidant properties of the various extracts and phytochemical constituents from Rumex acetosella L. · Journal of food biochemistry
- 4.PMID: 24430525 (1971) — The mechanism of sex determination in Rumex acetosella. · TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik
- 5.PMID: 33474359 (2018) — Characterization of the complete chloroplast genome of sorrel (Rumex acetosa).